|
|
 |
|
Viewing report
|
|
|
|
Anti-Infectives - Global Strategic Business Report
Global Industry Analysts, Inc., Feb 2010, Pages: 825
This report analyzes the worldwide markets for Anti-Infectives in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period 2006 through 2015. The report profiles 77 companies including many key and niche players worldwide such as Abbott Laboratories, Alcon Pharmaceuticals Ltd., Astellas Pharma, Inc., AstraZeneca PLC , Bayer HealthCare AG , Bristol-Myers Squibb Co., Boehringer Ingelheim, Cubist Pharmaceuticals, Inc., Daiichi Sankyo Company, Limited, Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline Plc, . F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sanofi-Aventis SA, and Wyeth Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Antibacterial Drugs - Global Strategic Business Report
Antivirals - Global Strategic Business Report
Human Vaccines - Global Strategic Business Report
Antibiotics - Global Strategic Business Report
Opthalmic Pharmaceutical Drugs - Global Strategic Business Report
The Antivirals Pipeline: Competitive Review
Anti-Infective Drugs Markets
H1N1 Vaccines - Global Strategic Business Report
Hepatitis C Viral Infection - After Protease Inhibitors What Is Next?
Innovations in Combating Infectious Diseases: Opportunities in Therapeutics and Diagnostics through Application of Proteomics, Genomics, Nanotechnology, and Novel Sources of Lead Generation
|
|
|
|
